Shanghai Pharmaceuticals Holding , Ltd Current Assets

The latest current assets for SHPMY is $190B as of June 2026. That compares with $180B in the prior-year period — up 2.2% year over year. Investors often review this figure alongside Shanghai Pharmaceuticals Holding , Ltd's historical trend and sector peers before judging valuation or financial health.

Over the past year, SHPMY's current assets moved from $180B to $190B — a 2.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Shanghai Pharmaceuticals Holding , Ltd's operating scale or balance-sheet position.

A current assets figure of $190B for SHPMY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SHPMY's current assets ($190B), review year-over-year change from $180B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.